|
06/08/2026 |
Medicine: Hyftor sirolimus
|
Updated |
|
06/08/2026 |
|
Updated |
|
06/08/2026 |
Medicine: Docetaxel Kabi docetaxel
|
Updated |
|
06/08/2026 |
Medicine: Synjardy empagliflozin; metformin
|
Updated |
|
06/08/2026 |
Medicine: Zynlonta loncastuximab tesirine
|
Updated |
|
06/08/2026 |
Medicine: Thiotepa Riemser thiotepa
|
Updated |
|
06/08/2026 |
Medicine: Neuraceq florbetaben (18F)
|
Updated |
|
06/08/2026 |
Medicine: Cholib fenofibrate; simvastatin
|
Updated |
|
06/08/2026 |
Medicine: MabThera rituximab
|
Updated |
|
06/08/2026 |
Medicine: Abrysvo respiratory syncytial virus vaccine (bivalent, recombinant)
|
Updated |
|
06/08/2026 |
Medicine: Breyanzi lisocabtagene maraleucel
|
Updated |
|
06/08/2026 |
Medicine: Idacio adalimumab
|
Updated |
|
06/08/2026 |
Medicine: Firazyr icatibant
|
Updated |
|
06/08/2026 |
Medicine: Tepkinly epcoritamab
|
Updated |
|
06/08/2026 |
Medicine: Comirnaty COVID-19 mRNA vaccine
|
Updated |
|
06/08/2026 |
Medicine: Cibinqo abrocitinib
|
Updated |
|
06/08/2026 |
Medicine: Ozawade pitolisant
|
Updated |
|
06/08/2026 |
|
Updated |
|
06/08/2026 |
Medicine: Deqtynet copper (64Cu) oxodotreotide
|
Updated |
|
06/08/2026 |
|
Updated |
|
06/08/2026 |
|
Updated |
|
06/08/2026 |
|
New |
|
06/08/2026 |
Referral: Tavneos - referral avacopan
|
Updated |
|
06/08/2026 |
|
Updated |
|
06/08/2026 |
Medicine: Wakix pitolisant
|
Updated |
|
06/08/2026 |
|
New |
|
05/08/2026 |
|
New |
|
05/08/2026 |
PSUSA: PSUSA/00000669/202512 - periodic safety update report single assessment chlorhexidine gluconate / isopropyl alcohol (covers other synonymous terms such as 2-propanol)
|
New |
|
05/08/2026 |
Medicine: Degarelix Accord degarelix
|
Updated |
|
05/08/2026 |
Medicine: Ninlaro ixazomib
|
Updated |
|
05/08/2026 |
Medicine: Nexpovio selinexor
|
Updated |
|
05/08/2026 |
Medicine: Kyprolis carfilzomib
|
Updated |
|
05/08/2026 |
|
Updated |
|
05/08/2026 |
Medicine: Humira adalimumab
|
Updated |
|
05/08/2026 |
Medicine: Leqembi lecanemab
|
Updated |
|
05/08/2026 |
Medicine: Arikayce liposomal amikacin
|
Updated |
|
05/08/2026 |
Medicine: Signifor pasireotide
|
Updated |
|
05/08/2026 |
Medicine: Iqirvo elafibranor
|
Updated |
|
05/08/2026 |
Medicine: Caprelsa vandetanib
|
Updated |
|
05/08/2026 |
|
Updated |
|
05/08/2026 |
Medicine: Kisqali ribociclib
|
Updated |
|
04/08/2026 |
Medicine: Loqtorzi toripalimab
|
Updated |
|
04/08/2026 |
Medicine: Silapo epoetin zeta
|
Updated |
|
04/08/2026 |
Medicine: Elmiron pentosan polysulfate sodium
|
Updated |
|
04/08/2026 |
Medicine: Obodence denosumab
|
Updated |
|
04/08/2026 |
Medicine: Bimervax COVID-19 Vaccine (recombinant, adjuvanted)
|
Updated |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
Medicine: Dzuveo sufentanil
|
Updated |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
Medicine: Qinlock ripretinib
|
Updated |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
Orphan: EU/3/07/523 - orphan designation for treatment of gastro-entero-pancreatic neuroendocrine tumours Lutetium (177Lu)-N-[(4,7,10-Tricarboxymethyl-1,4,7,10-tetraazacyclododec-1-yl)acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophanyl-L-lysyl-L-threoninyl-L-cysteinyl-L-threonine-cyclic(2-7)disulfide (lutetium (177Lu) oxodotreotide)
|
Updated |
|
04/08/2026 |
Orphan: EU/3/25/3118 - orphan designation for treatment of primary hyperoxaluria mRNA encoding Cas12HF endonuclease, Single guide RNA against the human HAO1 gene
|
Updated |
|
04/08/2026 |
Orphan: EU/3/25/3032 - orphan designation for treatment of Olmsted syndrome (R)-(3-(2'-cyclopropyl-3-(hydroxymethyl)-[1,1'-biphenyl]-4-yl)pyrrolidin-1-yl)(5-hydroxy-6-methylpyridin-2-yl)methanone
|
Updated |
|
04/08/2026 |
Orphan: EU/3/20/2286 - orphan designation for treatment of soft tissue sarcoma autologous CD4+ and CD8+ T cells transduced with a lentiviral vector encoding an affinity enhanced T cell receptor specific to MAGE-A4
|
Updated |
|
04/08/2026 |
Medicine: SomaKit TOC edotreotide
|
Updated |
|
04/08/2026 |
|
New |
|
04/08/2026 |
Medicine: Orserdu elacestrant
|
Updated |
|
04/08/2026 |
Medicine: Vitrakvi larotrectinib
|
Updated |
|
04/08/2026 |
Medicine: Skyclarys omaveloxolone
|
Updated |
|
04/08/2026 |
Medicine: Spinraza nusinersen
|
Updated |
|
04/08/2026 |
|
New |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
|
New |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
Medicine: Leflunomide medac leflunomide
|
Updated |
|
04/08/2026 |
Medicine: Twinrix Adult hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
|
Updated |
|
04/08/2026 |
Medicine: Orblid bevacizumab
|
Updated |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
|
New |
|
04/08/2026 |
|
Updated |
|
04/08/2026 |
Orphan: EU/3/16/1694 - orphan designation for treatment of soft tissue sarcoma autologous CD4+ and CD8+ T cells transduced with lentiviral vector containing an affinity-enhanced T-cell receptor targeting the New York esophageal antigen-1
|
Updated |
|
04/08/2026 |
|
Updated |
|
03/08/2026 |
Medicine: Vabysmo faricimab
|
Updated |
|
03/08/2026 |
|
Updated |
|
03/08/2026 |
Medicine: Takhzyro lanadelumab
|
Updated |
|
03/08/2026 |
Medicine: Lytenava bevacizumab
|
Updated |
|
03/08/2026 |
Medicine: Opzelura ruxolitinib
|
Updated |
|
03/08/2026 |
Medicine: Palsonify paltusotine
|
Updated |
|
03/08/2026 |
Medicine: Ambirix hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
|
Updated |
|
03/08/2026 |
Medicine: Twinrix Paediatric hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
|
Updated |
|
03/08/2026 |
|
Updated |
|
03/08/2026 |
|
New |
|
03/08/2026 |
|
New |
|
03/08/2026 |
|
Updated |
|
03/08/2026 |
|
New |
|
03/08/2026 |
|
New |
|
03/08/2026 |
|
Updated |
|
03/08/2026 |
|
Updated |
|
03/08/2026 |
|
New |
|
03/08/2026 |
|
New |
|
03/08/2026 |
|
New |
|
03/08/2026 |
|
Updated |
|
03/08/2026 |
|
Updated |
|
03/08/2026 |
|
Updated |